Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McLaughlin

Showing results (551-560 of 726) with videos related to

Pageof 73
Sort By:
The Journal of Biological Chemistry|November 5, 2003
Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic toleranceJay P McLaughlin, Lisa C Myers, Paul E Zarek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapyDavid C Miller, Martin G Sanda, Rodney L Dunn, et al.
International Journal of Food Microbiology|March 31, 2015
Carbohydrate catabolic diversity of bifidobacteria and lactobacilli of human originHeather P McLaughlin, Mary O'Connell Motherway, Bhuvaneswari Lakshminarayanan, et al.
ACS Chemical Neuroscience|May 21, 2021
Development of New Benzylpiperazine Derivatives as σ<sub>1</sub> Receptor Ligands with <i>in Vivo</i> Antinociceptive and Anti-Allodynic EffectsGiuseppe Romeo, Federica Bonanno, Lisa L Wilson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion scheduleA Younes, J P Ayoub, F B Hagemeister, et al.
Radiology|December 1, 1981
Treatment of stage I and II mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by laparotomyF B Hagemeister, L M Fuller, J A Sullivan, et al.
British Journal of Pharmacology|March 5, 2014
Alanine analogues of [D-Trp]CJ-15,208: novel opioid activity profiles and prevention of drug- and stress-induced reinstatement of cocaine-seeking behaviourJ V Aldrich, S N Senadheera, N C Ross, et al.
Clinical Breast Cancer|April 19, 2023
Evaluating the Necessity for Routine Sentinel Lymph Node Biopsy in Postmenopausal Patients Being Treated for Clinically Node Negative Breast Cancer the Era of RxPONDERMatthew G Davey, Eoin P Kerin, Ray P McLaughlin, et al.
Bioconjugate Chemistry|November 1, 1991
A novel heterobifunctional linker for formyl to thiol couplingN D Heindel, H R Zhao, R A Egolf, et al.
Leukemia & Lymphoma|February 26, 1999
Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphomaJ E Romaguera, F B Hagemeister, P McLaughlin, et al.
Pageof 73

Showing results (551-560 of 726) with videos related to

Sort By:
Pageof 73
The Journal of Biological Chemistry|November 5, 2003
Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic toleranceJay P McLaughlin, Lisa C Myers, Paul E Zarek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapyDavid C Miller, Martin G Sanda, Rodney L Dunn, et al.
International Journal of Food Microbiology|March 31, 2015
Carbohydrate catabolic diversity of bifidobacteria and lactobacilli of human originHeather P McLaughlin, Mary O'Connell Motherway, Bhuvaneswari Lakshminarayanan, et al.
ACS Chemical Neuroscience|May 21, 2021
Development of New Benzylpiperazine Derivatives as σ<sub>1</sub> Receptor Ligands with <i>in Vivo</i> Antinociceptive and Anti-Allodynic EffectsGiuseppe Romeo, Federica Bonanno, Lisa L Wilson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion scheduleA Younes, J P Ayoub, F B Hagemeister, et al.
Radiology|December 1, 1981
Treatment of stage I and II mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by laparotomyF B Hagemeister, L M Fuller, J A Sullivan, et al.
British Journal of Pharmacology|March 5, 2014
Alanine analogues of [D-Trp]CJ-15,208: novel opioid activity profiles and prevention of drug- and stress-induced reinstatement of cocaine-seeking behaviourJ V Aldrich, S N Senadheera, N C Ross, et al.
Clinical Breast Cancer|April 19, 2023
Evaluating the Necessity for Routine Sentinel Lymph Node Biopsy in Postmenopausal Patients Being Treated for Clinically Node Negative Breast Cancer the Era of RxPONDERMatthew G Davey, Eoin P Kerin, Ray P McLaughlin, et al.
Bioconjugate Chemistry|November 1, 1991
A novel heterobifunctional linker for formyl to thiol couplingN D Heindel, H R Zhao, R A Egolf, et al.
Leukemia & Lymphoma|February 26, 1999
Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphomaJ E Romaguera, F B Hagemeister, P McLaughlin, et al.
Pageof 73